Carillon Tower Advisers’s US Physical Therapy USPH Stock Holding History

Carillon Tower Advisers’s Portfolio USPH Stock Details USPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$6.17M	Sell	51,266 -1,600	-3%	-$161K	0.04%	388
2020 Q3	$4.59M	Sell	52,866 -1,385	-3%	-$119K	0.06%	344
2020 Q2	$4.39M	Sell	54,251 -900	-2%	-$65.6K	0.03%	381
2020 Q1	$3.81M	Sell	55,151 -5,700	-9%	-$601K	0.04%	353
2019 Q4	$6.96M	Sell	60,851 -2,000	-3%	-$249K	0.05%	367
2019 Q3	$8.21M	Sell	62,851 -500	-0.8%	-$65.1K	0.06%	351
2019 Q2	$7.76M	Hold	63,351	–	–	0.05%	357
2019 Q1	$6.65M	Sell	63,351 -625	-1%	-$67.2K	0.05%	363
2018 Q4	$6.55M	Sell	63,976 -12,900	-17%	-$1.43M	0.06%	342
2018 Q3	$9.12M	Sell	76,876 -4,864	-6%	-$549K	0.07%	346
2018 Q2	$7.85M	Sell	81,740 -1,060	-1%	-$98.3K	0.06%	343
2018 Q1	$6.73M	Buy	+82,800	New	+$6.42M	0.05%	346

Other funds holding USPH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Carillon Tower Advisers's USPH Position: Q4 2020 in Review

Carillon Tower Advisers reduced its US Physical Therapy (USPH) stake by 3% in Q4 2020, selling an estimated $161K and leaving 51,266 shares worth $6.17M. The position accounts for 0.04% of the portfolio, ranked #388.

Carillon Tower Advisers first reported a position in USPH in Q1 2018 and has held it in 12 quarters since. The position peaked at $9.12M in Q3 2018. 204 funds tracked by Wall St. Rank hold USPH as of Q4 2020.

Carillon Tower Advisers held 51,266 shares of US Physical Therapy worth $6.17M as of Q4 2020.
Carillon Tower Advisers sold 1,600 US Physical Therapy shares in Q4 2020, an estimated $161K.
US Physical Therapy made up 0.04% of Carillon Tower Advisers's portfolio in Q4 2020, its #388 holding.
Carillon Tower Advisers first reported a position in US Physical Therapy in Q1 2018 and has held it in 12 quarters since.
Carillon Tower Advisers's US Physical Therapy position peaked at $9.12M in Q3 2018.
204 funds tracked by Wall St. Rank held US Physical Therapy as of Q4 2020.

Based on Carillon Tower Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.